sequence id,run,hcv_wg_pipeline,pipeline_version,sample id,sample date,initial genotype,genotype,subtype,Genotyping CORE,Genotyping E1,Genotyping E2,Genotyping P7,Genotyping NS2,Genotyping NS3,Genotyping NS4A,Genotyping NS4B,Genotyping NS5A,Genotyping NS5B,patient id,treatment id,regime,treatment date,drug id,drug manufacturer,therapy class,city,country of birth,date of birth,diagnosis date,ethnicity,nationality,gender,hiv status
H210500364-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210500364,01-Nov-2019,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,10,5.0,-,05-Jan-1988,ombitasvir,AbbVie,NS5B nucleotide polymerase inhibitor,Edinburgh,Scotland,14-Dec-2067,15-Mar-1998,White,British,Male,No
H210500364-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210500364,01-Nov-2019,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,10,4.0,-,30-Jun-2011,ledipasvir,Gilead,NS5A inhibitor,Edinburgh,Scotland,14-Dec-2067,15-Mar-1998,White,British,Male,No
H210500364-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210500364,01-Nov-2019,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,10,6.0,-,30-Jun-2011,paritaprevir,AbbVie,NS3A/4A protease inhibitor,Edinburgh,Scotland,14-Dec-2067,15-Mar-1998,White,British,Male,No
H205140999-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H205140999,08-Mar-2020,3a,Check genotyping results by genes: NULL 3a 3,-,,,,3a,,3,3a,3a,3a,3a,40,,,,,,,-,England,04-Aug-1982,04-Jul-2003,White,British,Female,No
H210440756-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210440756,01-Oct-2020,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,41,,,,,,,-,Wales,06-Nov-2041,12-May-1991,Not Stated,British,Female,Yes
H210460580-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210460580,02-Apr-2021,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,42,,,,,,,-,Italy,21-Mar-1987,04-Nov-1990,White,Italian,Female,Yes
H210480169-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210480169,13-Aug-2020,2b,2,b,2b,2b,2b,2b,2b,2b,2b,2b,2b,2b,43,,,,,,,Derry,Northern Ireland,15-Jun-1989,17-Jan-1995,White,British,Male,Yes
H210480859-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210480859,19-Feb-2021,1a,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,44,,,,,,,-,France,12-Sep-2065,12-Aug-1988,White,Italian,Male,Yes
H210480865-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210480865,18-Aug-2019,1a,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,45,,,,,,,-,Russia,22-Apr-2061,26-Sep-2004,White,Russian,Male,Yes
H210480866-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210480866,18-May-2020,1a,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,46,,,,,,,London,Scotland,31-Jan-2040,07-Dec-2005,White,British,Male,Yes
H210480867-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210480867,05-Mar-2020,1a,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,47,,,,,,,-,Scotland,09-Feb-1983,25-Nov-1996,Other/Mixed,British,Female,No
H210480868-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210480868,24-Feb-2020,1a,Check genotyping results by genes: NULL 1a 1,-,,,,,,1a,1a,1a,1,1,48,,,,,,,-,England,06-Jun-2043,20-Mar-1994,Other/Mixed,British,Female,No
H210480869-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210480869,21-Nov-2019,1a,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,49,,,,,,,-,Russia,17-Sep-2058,01-May-1994,White,Russian,Female,Yes
H210480870-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210480870,02-Sep-2019,1a,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,50,,,,,,,-,England,26-Feb-2070,13-Oct-1995,White,British,Male,No
H210500285-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210500285,29-Apr-2019,1a,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,51,,,,,,,-,England,26-Aug-1985,08-May-1999,White,British,Male,No
H210500432-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210500432,21-Dec-2020,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,53,,,,,,,-,England,06-May-1974,06-Dec-1993,Asian,British,Male,No
H210520483-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210520483,28-Jun-2020,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,54,,,,,,,-,England,20-Jul-1976,28-Jan-1994,Black African,British,Male,Yes
H210520554-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210520554,18-Aug-2020,4d,4,d,4d,4d,4d,4d,4d,4d,4d,4d,4d,4d,55,,,,,,,London,Scotland,22-Jul-2049,22-Mar-1997,Black Caribbean,British,Female,Yes
H210520555-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210520555,30-Jul-2019,1a,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,56,,,,,,,London,Gibraltar,28-May-1977,10-Oct-1997,White,British,Female,Yes
H210520556-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210520556,06-Nov-2020,1a,Check genotyping results by genes: 1 1a,-,1,1a,1a,1a,1a,1a,1,1a,1a,1a,57,,,,,,,-,Germany,22-Feb-2050,03-Mar-2003,Asian,German,Female,Yes
H210520557-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210520557,08-Apr-2019,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,58,,,,,,,Cambridge,Ghana,26-Jul-2046,20-Jan-2005,White,British,Female,Yes
H210520558-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210520558,28-Jun-2019,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,59,,,,,,,-,England,17-Oct-1974,04-Feb-1998,White,British,Male,Yes
H210540062-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210540062,21-Jun-2020,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,60,,,,,,,Oxford,Brazil,19-Jan-1981,31-Jul-1991,White,Brazilian,Male,No
H210540115-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210540115,24-Dec-2020,2b,2,b,2b,2b,2b,2b,2b,2b,2b,2b,2b,2b,61,,,,,,,London,Portugal,17-Jul-2059,03-Aug-1991,White,Portuguese,Male,No
H210540116-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210540116,22-Jul-2020,1a,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,62,,,,,,,-,England,01-May-2067,05-Jan-1998,Other/Mixed,British,Male,Yes
H210540575-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210540575,05-Jul-2020,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,63,,,,,,,-,China,29-Feb-2048,29-Oct-1988,White,Chinese,Male,No
H210540581-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210540581,13-Aug-2019,1a,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,64,,,,,,,-,USA,24-Feb-1986,09-Sep-1994,Black African,British,Female,No
H210560613-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210560613,25-Dec-2019,1a,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,65,,,,,,,-,Russia,06-May-1971,24-Apr-1988,White,Russian,Female,No
H210560614-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210560614,12-Sep-2019,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,66,,,,,,,-,Korea,11-Dec-1982,28-May-1989,Asian,Korean,Female,Yes
H210560615-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210560615,05-Feb-2020,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,67,,,,,,,-,Ireland,14-Mar-2057,13-Dec-2000,White,Irish,Male,Yes
H210560616-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210560616,30-Sep-2020,1a,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,68,,,,,,,London,Ireland,13-Aug-2070,26-Dec-1995,White,Irish,Male,Yes
H210560748-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210560748,02-May-2019,1a,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,69,,,,,,,-,Spain,20-Oct-2051,01-Feb-1988,White,Spanish,Male,Yes
H210580669-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210580669,02-Aug-2020,3b,3,b,3b,3b,3b,3b,3b,3b,3b,3b,3b,3b,70,,,,,,,-,France,18-Apr-1975,19-Oct-2003,White,French,Male,Yes
H210580670-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210580670,01-Dec-2020,1b,1,b,1b,1b,1b,1b,1b,1b,1b,1b,1b,1b,71,,,,,,,-,Kenya,21-Feb-2041,19-May-2003,Asian,Kenyan,Female,Yes
H210580671-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210580671,23-Dec-2019,1a,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,72,,,,,,,-,France,25-Oct-1973,21-May-1988,Black African,Italian,Female,No
H210580672-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210580672,23-Feb-2021,1a,Check genotyping results by genes: 1a 1,-,1a,1a,1a,1a,1a,1a,1a,1,1a,1a,73,,,,,,,-,Russia,15-Sep-1980,24-Apr-1993,White,Russian,Female,No
H210580673-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210580673,18-Jan-2020,1a,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,74,,,,,,,London,Scotland,29-Sep-1975,12-Dec-1995,White,British,Female,Yes
H210580674-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210580674,31-Mar-2020,1a,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,75,,,,,,,-,Scotland,01-Jul-2041,17-Nov-2004,White,British,Male,No
H210580675-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210580675,06-May-2020,1a,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,76,,,,,,,-,England,05-Oct-1979,31-Oct-1991,White,British,Male,No
H210580676-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210580676,29-Apr-2019,1a,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,77,10.0,1 tablet per day,30-Jun-2011,simeprevir,Janssen,NS3A/4A protease inhibitor,London,Russia,08-Oct-2060,04-Feb-1990,White,Russian,Male,No
H210600302-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210600302,21-Feb-2021,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,78,,,,,,,London,England,08-Mar-2067,05-Dec-2004,White,British,Male,Yes
H210600303-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210600303,01-Jun-2019,1a,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,79,,,,,,,Manchester,England,18-Sep-2062,30-Dec-2005,White,British,Male,Yes
H210600362-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210600362,08-Oct-2020,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,80,,,,,,,London,England,08-Dec-2049,27-Apr-1990,White,British,Female,Yes
H210640639-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210640639,06-Aug-2019,2c,2,c,2c,2c,2c,2c,2c,2c,2c,2c,2c,2c,81,,,,,,,Salisbury,England,10-Aug-1987,24-May-2005,White,British,Female,Yes
H210660797-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210660797,23-Jun-2019,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,82,,,,,,,-,Scotland,16-Aug-2047,11-Jun-1998,White,British,Female,Yes
H210660798-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210660798,10-Jan-2020,1a,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,83,,,,,,,-,Gibraltar,05-May-1974,24-Mar-1990,Other/Mixed,British,Male,Yes
H210660799-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210660799,17-Apr-2020,1a,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,84,,,,,,,-,Cuba,25-Jan-2069,24-Dec-2003,White,Cuban,Male,No
H210680422-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210680422,24-Dec-2019,3a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,85,,,,,,,London,Ghana,16-Oct-1986,08-Jun-1989,Asian,British,Male,No
H210680671-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210680671,02-Dec-2020,1a,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,86,,,,,,,-,England,20-Nov-1977,25-Dec-2002,White,British,Male,Yes
H210680672-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210680672,08-Feb-2021,1a,Check genotyping results by genes: 1b 1,-,1b,1b,1b,1b,1b,1b,1,1b,1b,1b,87,,,,,,,London,Brazil,07-Aug-2065,02-Oct-2003,White,Brazilian,Male,No
H210680673-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210680673,12-Dec-2020,1a,2,b,2b,2b,2b,2b,2b,2b,2b,2b,2b,2b,88,,,,,,,-,Portugal,09-May-1989,22-Jul-1996,White,Portuguese,Female,No
H210680674-1_NGS92,NGS92,PHE HCV bioinformatics pipeline,version 1.0,H210680674,07-Jul-2020,1a,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,89,,,,,,,London,England,03-Apr-1975,08-Sep-1988,White,British,Female,No
